LevitasBio
About:
LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.
Website: http://levitasbio.com/
Top Investors: Decheng Capital, Pavilion Capital, Novalis LifeSciences
Description:
Levitas is redefining cellular analytics with its novel platform of magnetic levitation technology. Their disruptive technology overcomes the current technological limitations of cellular analysis by providing label-free, simple, and universal methods of analysis. The company's platform, the LeviCell enables studies and beneficial uses of previously inaccessible, high-value primary samples and sensitive cell types regardless of the starting cell number, viability, or sensitivity to processing.
$72.8M
$10M to $50M
San Francisco, California, United States
2017-01-01
Gozde Durmus, Lars Steinmetz, Utkan Demirci
51-100
2024-03-28
Private
© 2025 bioDAO.ai